EBAC

European Biotech Acquisition Corp. Class A Ordinary Shares

Delisted

EBAC was delisted on the 2nd of March, 2023.

0 hedge funds and large institutions have $0 invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1 -$12.7M
2 -$7.85M
3 -$5.99M
4
Macquarie Group
Macquarie Group
Australia
-$5.09M
5
LA
Linden Advisors
New York
-$5.03M